1.Inhibitory effect of ulinastatin on osteoclast activation and the relationship of ulinastatin to matrix metalloproteinase-2 and matrix metalloproteinase-9:potential of preventing prosthetic osteolysis
Jiangying RU ; Jianning ZHAO ; Ting GUO ; Lei YU ; Hao DING ; Hui JIANG
Chinese Journal of Tissue Engineering Research 2014;(35):5633-5639
BACKGROUND:It is presumed that urinary trypsin inhibitor could have protective effects on local and systemic tissues and could inhibit osteoclast proliferation and activation under long-term chronic inflammation conditions and in ischemic and anoxic environment which was induced by prosthetic wear. OBJECTIVE:To investigate the inhibitory effect of ulinastatin on receptor activator for nuclear factor-κb ligand-induced differentiation, proliferation and osteoclastogenesis of RAW264.7 cells and its effects on matrix metal oproteinase-2, matrix metal oproteinase-9 expression level and activity. METHODS:Mouse monocyte/macrophage cellline RAW264.7 was treated with different concentrations of urinary trypsin inhibitor (0, 500, 5 000 U/mL) for 24, 48 and 72 hours. Experiments were divided into four groups:the blank group (RAW264.7 cells), receptor activator for nuclear factor-κb ligand-induced group (0 U/mL ulinastatin), 500 U/mL ulinastatin group and 5 000 U/mL ulinastatin group. RESULTS AND CONCLUSION:(1) MTT results indicated that there was no significant difference on the proliferation of RAW264.7 cells treated with urinary trypsin inhibitor at 0-5 000 U/mL (P>0.05) (2) Tartrate-resistant acid phosphatase staining results revealed that compared with receptor activator for nuclear factor-κb ligand-induced group, the number of tartrate-resistant acid phosphatase-positive cells was significantly less in the ulinastatin group (P<0.05), showing a time-dose dependent manner. (3) Immunohistochemisical results found that compared with receptor activator for nuclear factor-κb ligand-induced group, the percentage of matrix metal oproteinase-9-positive cells was apparently lower in the ulinastatin group. (4) Western blot assay results demonstrated that matrix metal oproteinase-9 expression was low in the RAW264.7 cells alone. At 48 hours after addition of receptor activator for nuclear factor-κb ligand, matrix metal oproteinase-9 protein expression was large. At 72 hours after culture in the 5 000 U/mL ulinastatin group, matrix metal oproteinase-9 protein expression was evidently reduced. (5) Gelatin zymography results showed that compared with the receptor activator for nuclear factor-κb ligand-induced group, matrix metal oproteinase-9 expression was significantly lower in the 5 000 U/mL ulinastatin group (P<0.05). Results suggested that urinary trypsin inhibitor inhibited receptor activator for nuclear factor-κb ligand-induced osteoclastogenesis and diminished matrix metal oproteinase-9 expression and activity.
2.Ulinastatin intervention for polymethyl methacrylate-induced MC3T3-E1 mouse preosteoblast apoptosis
Jiangying RU ; Yu CONG ; Jianning ZHAO ; Ting GUO ; Lei YU ; Hao DING ; Hui JIANG
Chinese Journal of Tissue Engineering Research 2014;(43):6945-6950
BACKGROUND:Previous studies have indicated that ulinastatin can inhibit RANKL-induced osteoclastogenesis on RAW264.7 cells and also lower matrix metal oproteinase-9 expression and activity. However, it remains be unclear whether ulinastatin has the intervention effect on polymethyl methacrylate (PMMA)-induced MC3T3-E1 mouse preosteoblast apoptosis or not. <br> OBJECTIVE:To explore the intervention role of ulinastatin on the PMMA-induced MC3T3-E1 mouse preosteoblast apoptosis and its effects on type I col agen, osteocalcin, matrix metal oproteinase-2 mRNA expression. <br> METHODS:MC3T3-E1 mouse preosteoblasts at passages 6 and 7 were divided into four groups:blank group (only cultured MC3T3-E1 mouse preosteoblast), PMMA-induced group (MC3T3-E1 mouse preosteoblast+1 g/L PMMA bone cement suspension), low dose ulinastatin group (MC3T3-E1 mouse preosteoblast+1 g/L PMMA bone cement suspension+500 U/mL ulinastatin) and high dose ulinastatin group (MC3T3-E1 mouse preosteoblast+1 g/L PMMA bone cement suspension+5 000 U/mL ulinastatin). MTT method was adopted to detect the proliferation activity of proliferative activity of MC3T3-E1 mouse preosteoblast;alizarin red staining method was used to observe mineralization nodules of MC3T3-E1 mouse preosteoblast among different groups;the change of apoptosis rate for MC3T3-E1 cells was detected by flow cytometry analysis;semi-quantitative RT-PCR was taken to analyze type I col agen, osteocalcin, matrix metal oproteinase-2 mRNA expression level in MC3T3-E1 mouse preosteoblasts among different groups. <br> RESULTS AND CONCLUSION:Compared with the blank group, PMMA significantly inhibited the proliferation activity of MC3T3-E1 mouse preosteoblast (P<0.05), and however significantly promoted cells apoptosis (P<0.05). After addition of different concentrations of ulinastatin (500, 5 000 U/mL), the proliferation activity of MC3T3-E1 mouse preosteoblasts significantly raised (P<0.05), and cells apoptosis rate significantly decreased (P<0.05), showing the dose and time-dependent relation. Type I col agen and osteocalcin mRNA expression levels both significantly decreased after co-culture in PMMA group compared with the blank group (P<0.05), matrix metal oproteinase-2 mRNA expression level, however, significantly increased (P<0.05). After intervention with 5000 U/mL ulinastatin, type I col agen and osteocalcin mRNA expression levels both significantly increased, while matrix metal oproteinase-2 mRNA expression level significantly decreased (P<0.05). PMMA group showed no obvious mineralization nodules. Yet, mineralization nodules were formed in the blank group, high and low dose ulinastatin groups. These results indicate that ulinastatin could have the inhibitory effect on the PMMA-induced MC3T3-E1 mouse preosteoblast apoptosis, and it could promote type I col agen and osteocalcin mRNA expression and yet suppress matrix metal oproteinase-2 mRNA expression.
3.Health condition of workers exposed to silica dust in 6 quartz processing industry enterprises in Lianyungang city.
Ya-ping HUO ; Ri-hui ZHOU ; Bo SUN ; Bao-li ZHU ; Ru-yan YNAG ; Fang-wen GONG ; Li-zhuang XIE ; Bang-mei DING
Chinese Journal of Industrial Hygiene and Occupational Diseases 2013;31(11):849-850
Adolescent
;
Adult
;
Dust
;
analysis
;
Female
;
Health Status
;
Humans
;
Industry
;
Male
;
Middle Aged
;
Occupational Exposure
;
analysis
;
Quartz
;
Young Adult
4.Comparison of mannitol and hypertonic saline in treatment of intracranial hypertension of rabbits.
Shu-qin LIU ; Ke-na ZHANG ; Hui-xia ZHENG ; Ru-huan MEI ; Xiong ZHANG ; Yue-min DING
Journal of Zhejiang University. Medical sciences 2012;41(2):166-170
OBJECTIVETo compare the effects of mannitol and hypertonic saline (HS) in treatment of intracranial hypertension (ICH) of rabbits.
METHODSThe animal mode of ICH was established by perfusing artificial cerebrospinal fluids (aCSF) with controlled pressure into the cerebral ventricles of rabbits. The mean arterial pressure, respiratory rate, tidal volume, perfusion rate of aCSF and water content of cerebrum were investigated in rabbits with ICH after a single bolus of 20% mannitol (5 ml/kg), 7.5% HS (2.2 ml/kg) or 23.4% HS (2.2 ml/kg).
RESULTSAfter the intracranial pressure was elevated from 15 cmH₂O to 75 cmH₂O, the mean arterial pressure was increased and the tidal volume was decreased. After treatment by 20% mannitol, 7.5% HS or 23.4% HS, the increased percentage of mean arterial pressure and the decreased percentage of tidal volume were similar to the changes in control group. However, the perfusion rate of CSF was increased and water content of cerebrum was decreased after treatment by either 20% mannitol or 23.4% HS, but not by 7.5% HS. No different effects were found between 20% mannitol and 23.4% HS.
CONCLUSIONWith the similar osmotic burden, 20% mannitol is more effective in treating ICH than 7.5% HS. With higher osmotic load, the efficacy of HS is enhanced, and 23.4% HS may be used as an alternative to mannitol in treatment of ICH.
Animals ; Disease Models, Animal ; Female ; Intracranial Hypertension ; drug therapy ; Male ; Mannitol ; administration & dosage ; therapeutic use ; Rabbits ; Saline Solution, Hypertonic ; administration & dosage ; therapeutic use
5.A new statistical method on familial correlation dealing with family data from case-control studies.
Yan-hui GAO ; Qing-wu JIANG ; Xue-fu ZHOU ; Bao-guo DING ; Ru-hong WANG ; Gen-ming ZHAO
Chinese Journal of Epidemiology 2004;25(11):992-996
OBJECTIVEThis paper presents a statistical method of familial correlation on family data from case-control studies.
METHODSMarginal mean models of the probands and the relatives conditional on the proband's disease status, as well as the marginal association model of the relatives were modeled integrately. Conditional odds-ratio and marginal odds-ratio were used to measure the familial correlation.
RESULTSThe parameter's interpretation in the model was in accordance with sample characteristics. This method is more efficient due to making fully use of information of the probands and relatives. In addition, the method has all advantages of GEE2.
CONCLUSIONThe method in this paper efficiently and conveniently analyzes the family data from case-control studies to estimate the familial correlation on disease.
Bias ; Case-Control Studies ; China ; epidemiology ; Data Interpretation, Statistical ; Epidemiologic Methods ; Family Health ; Female ; Humans ; Liver Neoplasms ; epidemiology ; genetics ; Logistic Models ; Male ; Odds Ratio ; Ovarian Neoplasms ; epidemiology ; genetics ; Risk Factors
6.Study on the maternal mortality ratio from 1995 to 2004 among residential and migrant women in Beijing.
Ru-gang SHEN ; Hui-juan YANG ; He LI ; Fang HE ; Hui DING ; Xiao-hong DENG ; Xun XIAO ; Gang LIU
Chinese Journal of Epidemiology 2006;27(3):223-225
OBJECTIVETo analyze the maternal mortality ratio (MMR) of residential and migrant women in Beijing.
METHODSA retrospective study from 1995 to 2004 was performed to analyze data from the maternal death cases.
RESULTSThe MMR of resident and migrant of Beijing from 1995 to 2004 were 17.9 and 51.3 per ten thousand respectively. The main reasons of maternal deaths among residents were embolism (21.2%), hypertensive disorder complicating pregnancy (18.3%), postpartum hemorrhage (14.4%) and ectopic pregnancy/heart disease (9.6%). The main reasons of migrant maternal deaths were postpartum hemorrhage (25.2%), embolism (19.7%), hypertensive disorder complicating pregnancy (17.3%) and liver disease (9.5%). The avoidable deaths were accounted for 18.9%.
CONCLUSIONThe MMR in Beijing local residents was close to that in developed countries. To further reduce MMR in Beijing would depend on the better administration of related issues among floating population. Poor quatily delivery must be banned together with strengthening the training programs on health workers. It is also important to improve the knowledge and skills of medical staff for rescuing the complications of pregnancy and ectopic pregnancy.
China ; epidemiology ; Female ; Humans ; Liver Diseases ; mortality ; Maternal Health Services ; Maternal Mortality ; Postpartum Hemorrhage ; mortality ; Pregnancy ; Pregnancy Complications ; mortality ; Pregnancy Complications, Cardiovascular ; mortality ; Retrospective Studies ; Transients and Migrants ; statistics & numerical data
7.Comparison of clinical efficacy of orthotopic ileal neobladder versus orthotopic sigmoid neobladder
Jian-Song WANG ; Hong-Yi XU ; Yong-Fu SHI ; Hui ZHAN ; Jong-Ming LI ; Ze-Hui LI ; Yi-Gang ZUO ; Delin YANG ; Chao WANG ; Chang-xing KE ; Ming-xia DING ; Ru-ping YAN
Chinese Journal of Urology 2000;0(12):-
Objective To compare the clinical efficacy of orthotopic ileal neobladder versus ortho- topic sigmoid neobladder.Methods The data of 96 patients who had undergone orthotopic ileal neoblad- der and 68 patients who had undergone orthotopic sigmoid neobladder were retrospectively analyzed.The perioperative condition,urinary continence,urodynamics,and pouch-related complications were compared between the 2 groups.Results Of all the 164 patients,12(7.3%)were lost to follow-up.The mean fol- low-up was 46(2-86)months in orthotopic ileal neobladder group,and 42(4-78)months in orthotopic sigmoid neobladder group.There was no significant difference in intraoperative blood loss and postoperative urinary continence between the 2 approaches(P>0.05).However,compared with sigmoid neobladder group,ileal neobladder group had longer operative time and postoperative recovery time,and got a bigger pouch(P<0.05).The early and late pouch-related complication rates of ileal neohladder group were 16. 7% and 29.2%,which were higher than those of sigmoid neobladder group.During the follow-up,tumor recurred in 3 cases of ileal neobladder group,but none in sigmoid neobladder group.Conclusions Ortho- topic ileal neobladder and sigmoid neobladder are similar in operative difficulties,and both can achieve satis- factory clinical results.Compared with ileal neobladder,sigmoid neobladder has shorter operative time, quicker recovery and lower rate of pouch-related complications,thus is a preferred procedure.
8.Value of galactose-deficient IgA1 in the early diagnosis of Henoch-Schönlein purpura nephritis in children.
Zhi-Juan KANG ; Bo LIU ; Zhi-Hui LI ; Cui-Rong DUAN ; Tian-Hui WU ; Man XUN ; Yi ZHANG ; Yun-Feng DING ; Ru-Qian FU
Chinese Journal of Contemporary Pediatrics 2019;21(2):172-175
OBJECTIVE:
To explore the value of galactose-deficient IgA1 (Gd-IgA1) in the early diagnosis of Henoch-Schönlein purpura nephritis (HSPN) in children.
METHODS:
A total of 67 hospitalized children who were definitely diagnosed with HSPN between January and April 2018 and 58 hospitalized children with Henoch-Schönlein purpura (HSP) were enrolled in the study. Twenty children undergoing routine physical examinations served as controls. The levels of serum and urine Gd-IgA1 were determined using ELISA. The receiver operating characteristic curve was used to analyze the value of serum Gd-IgA1 and urine Gd-IgA1/urine creatinine ratio in the diagnosis of HSPN.
RESULTS:
The level of serum Gd-IgA1 and urine Gd-IgA1/urine creatinine ratio in children with HSP or HSPN were significantly higher than those in healthy control group (P<0.01), with a significantly greater increase observed in children with HSPN (P<0.01). Serum Gd-IgA1 ≥1 485.57 U/mL and/or urine Gd-IgA1/urine creatinine ratio ≥105.74 were of favorable value in the diagnosis of HSPN. During the six-month follow-up of the 49 children with HSP, the incidence of HSPN was 47% (23/49), which included a 100% incidence in children with serum Gd-IgA1 ≥1 485.57 U/mL and a 73% incidence in children with urine Gd-IgA1/urine creatinine ratio ≥105.74.
CONCLUSIONS
Serum and urine Gd-IgA1 is of favorable clinical value in the early diagnosis of HSPN.
Child
;
Early Diagnosis
;
Galactose
;
Glomerulonephritis, IGA
;
Humans
;
Immunoglobulin A
;
Purpura, Schoenlein-Henoch
9.Treatment of ureaplasma urealyticum infection patients of Qi deficiency blood stasis syndrome by pengyan pill: a clinical observation.
Wen-E LIU ; Zhen-Yu TAN ; Ru-Yi XIA ; Zhi-Xiang ZOU ; Wei-Hui GAO ; Ji-Lin KUANG ; Liang-lian DING
Chinese Journal of Integrated Traditional and Western Medicine 2013;33(5):590-593
OBJECTIVETo observe the clinical efficacy of penyan pill (PP) in treating ureaplasma urealyticum (UU) infection patients of qi deficiency blood stasis syndrome (QDBSS).
METHODSTotally 188 UU infection patients of QDBSS were randomly assigned to two groups, the treatment group and the control group. Patients in the treatment group were treated with PP (10 g each time, thrice daily, 14 consecutive days as one therapeutic course), while those in the control group took azithromycin (10 g each day, 7 consecutive days as one therapeutic course). They were continually treated for 3 therapeutic courses. The clinical symptom integrals were observed in the two groups before and after treatment. The short-term efficacy was judged. Their recurrence rates were followed-up to assess their long-term efficacies.
RESULTSThe total effective rate of the comprehensive efficacy in the treatment group was 91.4%, while it was 79. 3%in the control group, showing no statistical difference between the two groups (P > 0.05). Better effects were obtained in improving Chinese medical clinical symptoms in the treatment group (P <0.01). There was no statistical difference in the negative conversion rate between the two groups after treatment (P >0. 05). There was statistical difference in the recurrence rate between the two groups (12. 82% vs 54.76%,P <0. 05).
CONCLUSIONSPP showed equivalent effects in treating UU infection patients of QDBSS to those of azithromycin. But PP showed obvious advantages over azithromycin in improving Chinese medical syndromes.
Adult ; Azithromycin ; therapeutic use ; Drugs, Chinese Herbal ; therapeutic use ; Female ; Humans ; Medicine, Chinese Traditional ; Middle Aged ; Phytotherapy ; Ureaplasma Infections ; diagnosis ; drug therapy ; Ureaplasma urealyticum
10.In vivo distribution of FITC-labeled boanmycin hydrochloride in situ gel.
Zhi-Hui WANG ; Wei-Ming DING ; Lin-Xue QIAN ; Mei LI ; Hong-Zhang XU ; Ru-Xian CHEN
Acta Pharmaceutica Sinica 2012;47(5):634-639
This study is to evaluate the sustained-release effect of the thermosensitive in situ gel for injection of boanmycin hydrochloride (BAM) by bioluminescence imaging in nude mice. BAM was labeled with fluorescein isothiocyanate (FITC). The FITC-labeled BAM (FITC-BAM) was purified by dialysis and Sephadex G25 gel column, and then was identified by matrix-assisted laser desorption ionization/time of flight (MALDI-TOF). The model of experimental hepatoma HepG-2 nude mice was established, and the optical imaging system was applied to evaluate the distribution of FITC-BAM in vivo. Results of MALDI-TOF proved that the major molecular ratio of BAM : FITC was 1 : 1 or 1 : 2. Bioluminescence imaging showed that the diffusion of FITC-BAM in situ gel group was significantly delayed compared with the negative control group. This study demonstrated that the thermosensitive in situ gel can effectively delay the release of boanmycin hydrochloride, and extend the retention time in vivo.
Animals
;
Antibiotics, Antineoplastic
;
administration & dosage
;
chemistry
;
pharmacokinetics
;
Bleomycin
;
administration & dosage
;
analogs & derivatives
;
chemistry
;
pharmacokinetics
;
Delayed-Action Preparations
;
Drug Carriers
;
chemistry
;
Female
;
Fluorescein-5-isothiocyanate
;
administration & dosage
;
chemistry
;
pharmacokinetics
;
Gels
;
chemistry
;
Hep G2 Cells
;
Humans
;
Injections
;
Mice
;
Mice, Inbred BALB C
;
Mice, Nude
;
Neoplasm Transplantation
;
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
;
Temperature
;
Tissue Distribution
;
Viscosity